nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2D6—breast cancer	0.125	0.384	CbGaD
Pethidine—CYP3A4—breast cancer	0.107	0.329	CbGaD
Pethidine—ALB—breast cancer	0.0932	0.287	CbGaD
Pethidine—CYP2B6—Thiotepa—breast cancer	0.0421	0.105	CbGbCtD
Pethidine—CYP2B6—Raloxifene—breast cancer	0.0281	0.0703	CbGbCtD
Pethidine—CYP2C19—Lapatinib—breast cancer	0.0236	0.059	CbGbCtD
Pethidine—CYP3A4—Exemestane—breast cancer	0.0225	0.0564	CbGbCtD
Pethidine—CYP2D6—Idarubicin—breast cancer	0.0204	0.0509	CbGbCtD
Pethidine—CYP3A4—Letrozole—breast cancer	0.0192	0.0479	CbGbCtD
Pethidine—CYP2B6—Tamoxifen—breast cancer	0.0186	0.0465	CbGbCtD
Pethidine—CYP3A4—Anastrozole—breast cancer	0.0171	0.0427	CbGbCtD
Pethidine—CYP3A4—Toremifene—breast cancer	0.0156	0.0391	CbGbCtD
Pethidine—CYP3A4—Fulvestrant—breast cancer	0.0145	0.0363	CbGbCtD
Pethidine—CYP2B6—Irinotecan—breast cancer	0.0143	0.0357	CbGbCtD
Pethidine—ALB—Irinotecan—breast cancer	0.014	0.035	CbGbCtD
Pethidine—ALB—Fluorouracil—breast cancer	0.0134	0.0336	CbGbCtD
Pethidine—CYP3A4—Thiotepa—breast cancer	0.0129	0.0324	CbGbCtD
Pethidine—CYP3A4—Ixabepilone—breast cancer	0.0118	0.0296	CbGbCtD
Pethidine—CYP2C19—Tamoxifen—breast cancer	0.0118	0.0295	CbGbCtD
Pethidine—CYP3A4—Lapatinib—breast cancer	0.0114	0.0285	CbGbCtD
Pethidine—CYP2D6—Vinorelbine—breast cancer	0.00994	0.0249	CbGbCtD
Pethidine—CYP2D6—Tamoxifen—breast cancer	0.00897	0.0224	CbGbCtD
Pethidine—CYP3A4—Raloxifene—breast cancer	0.00864	0.0216	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—breast cancer	0.00779	0.0195	CbGbCtD
Pethidine—ALB—Methotrexate—breast cancer	0.0074	0.0185	CbGbCtD
Pethidine—CYP3A4—Vinorelbine—breast cancer	0.00632	0.0158	CbGbCtD
Pethidine—CYP2D6—Vinblastine—breast cancer	0.00613	0.0153	CbGbCtD
Pethidine—CYP3A4—Tamoxifen—breast cancer	0.00571	0.0143	CbGbCtD
Pethidine—CYP3A4—Mitoxantrone—breast cancer	0.00557	0.0139	CbGbCtD
Pethidine—CYP3A4—Paclitaxel—breast cancer	0.00444	0.0111	CbGbCtD
Pethidine—CYP3A4—Irinotecan—breast cancer	0.00438	0.011	CbGbCtD
Pethidine—CYP3A4—Vinblastine—breast cancer	0.0039	0.00974	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—breast cancer	0.00376	0.00941	CbGbCtD
Pethidine—CYP3A4—Docetaxel—breast cancer	0.00321	0.00803	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—breast cancer	0.00239	0.00599	CbGbCtD
Pethidine—Etomidate—SLC2A1—breast cancer	0.00192	0.435	CrCbGaD
Pethidine—Ketobemidone—PTGS1—breast cancer	0.000546	0.123	CrCbGaD
Pethidine—Cyclopentolate—BCHE—breast cancer	0.000393	0.0889	CrCbGaD
Pethidine—Etomidate—CYP19A1—breast cancer	0.000362	0.082	CrCbGaD
Pethidine—Ketobemidone—CYP3A4—breast cancer	0.000319	0.0721	CrCbGaD
Pethidine—Levomilnacipran—CYP2D6—breast cancer	0.000262	0.0592	CrCbGaD
Pethidine—Levomilnacipran—CYP3A4—breast cancer	0.000225	0.0508	CrCbGaD
Pethidine—Glutethimide—CYP2D6—breast cancer	0.000204	0.046	CrCbGaD
Pethidine—Levomilnacipran—ABCB1—breast cancer	0.000187	0.0423	CrCbGaD
Pethidine—Dermatitis—Goserelin—breast cancer	0.00011	0.000712	CcSEcCtD
Pethidine—Somnolence—Fluorouracil—breast cancer	0.000109	0.000711	CcSEcCtD
Pethidine—Headache—Goserelin—breast cancer	0.000109	0.000708	CcSEcCtD
Pethidine—Anxiety—Paclitaxel—breast cancer	0.000109	0.000708	CcSEcCtD
Pethidine—Erythema—Docetaxel—breast cancer	0.000109	0.000707	CcSEcCtD
Pethidine—Decreased appetite—Gemcitabine—breast cancer	0.000109	0.000707	CcSEcCtD
Pethidine—Nausea—Tamoxifen—breast cancer	0.000108	0.000703	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—breast cancer	0.000107	0.000697	CcSEcCtD
Pethidine—Constipation—Gemcitabine—breast cancer	0.000107	0.000695	CcSEcCtD
Pethidine—Decreased appetite—Fluorouracil—breast cancer	0.000107	0.000695	CcSEcCtD
Pethidine—Dry mouth—Paclitaxel—breast cancer	0.000107	0.000694	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—breast cancer	0.000107	0.000694	CcSEcCtD
Pethidine—Asthenia—Thiotepa—breast cancer	0.000107	0.000693	CcSEcCtD
Pethidine—Nausea—Melphalan—breast cancer	0.000106	0.000688	CcSEcCtD
Pethidine—Feeling abnormal—Mitoxantrone—breast cancer	0.000106	0.000688	CcSEcCtD
Pethidine—Feeling abnormal—Irinotecan—breast cancer	0.000106	0.000688	CcSEcCtD
Pethidine—Confusional state—Paclitaxel—breast cancer	0.000106	0.000686	CcSEcCtD
Pethidine—Erythema—Capecitabine—breast cancer	0.000105	0.000684	CcSEcCtD
Pethidine—Pruritus—Thiotepa—breast cancer	0.000105	0.000684	CcSEcCtD
Pethidine—Oedema—Paclitaxel—breast cancer	0.000105	0.000681	CcSEcCtD
Pethidine—Anaphylactic shock—Paclitaxel—breast cancer	0.000105	0.000681	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—breast cancer	0.000105	0.00068	CcSEcCtD
Pethidine—Nausea—Goserelin—breast cancer	0.000103	0.000671	CcSEcCtD
Pethidine—Feeling abnormal—Gemcitabine—breast cancer	0.000103	0.00067	CcSEcCtD
Pethidine—Shock—Paclitaxel—breast cancer	0.000103	0.00067	CcSEcCtD
Pethidine—Dizziness—Vinorelbine—breast cancer	0.000103	0.000669	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000103	0.000669	CcSEcCtD
Pethidine—Tachycardia—Paclitaxel—breast cancer	0.000102	0.000664	CcSEcCtD
Pethidine—Urticaria—Mitoxantrone—breast cancer	0.000102	0.000663	CcSEcCtD
Pethidine—Feeling abnormal—Fluorouracil—breast cancer	0.000101	0.000659	CcSEcCtD
Pethidine—Muscle spasms—Capecitabine—breast cancer	0.000101	0.000658	CcSEcCtD
Pethidine—Hyperhidrosis—Paclitaxel—breast cancer	0.000101	0.000658	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—breast cancer	0.0001	0.000652	CcSEcCtD
Pethidine—Anorexia—Paclitaxel—breast cancer	9.99e-05	0.000649	CcSEcCtD
Pethidine—Vomiting—Vinorelbine—breast cancer	9.91e-05	0.000643	CcSEcCtD
Pethidine—Tremor—Capecitabine—breast cancer	9.88e-05	0.000641	CcSEcCtD
Pethidine—Dizziness—Thiotepa—breast cancer	9.84e-05	0.000639	CcSEcCtD
Pethidine—Rash—Vinorelbine—breast cancer	9.83e-05	0.000638	CcSEcCtD
Pethidine—Dermatitis—Vinorelbine—breast cancer	9.82e-05	0.000637	CcSEcCtD
Pethidine—Hypotension—Paclitaxel—breast cancer	9.8e-05	0.000636	CcSEcCtD
Pethidine—Urticaria—Fluorouracil—breast cancer	9.78e-05	0.000635	CcSEcCtD
Pethidine—Headache—Vinorelbine—breast cancer	9.76e-05	0.000634	CcSEcCtD
Pethidine—Syncope—Docetaxel—breast cancer	9.76e-05	0.000634	CcSEcCtD
Pethidine—Sweating—Methotrexate—breast cancer	9.63e-05	0.000625	CcSEcCtD
Pethidine—Palpitations—Docetaxel—breast cancer	9.62e-05	0.000625	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—breast cancer	9.57e-05	0.000621	CcSEcCtD
Pethidine—Insomnia—Paclitaxel—breast cancer	9.48e-05	0.000616	CcSEcCtD
Pethidine—Vertigo—Capecitabine—breast cancer	9.47e-05	0.000615	CcSEcCtD
Pethidine—Hypersensitivity—Mitoxantrone—breast cancer	9.47e-05	0.000615	CcSEcCtD
Pethidine—Hypersensitivity—Irinotecan—breast cancer	9.47e-05	0.000615	CcSEcCtD
Pethidine—Vomiting—Thiotepa—breast cancer	9.46e-05	0.000614	CcSEcCtD
Pethidine—Syncope—Capecitabine—breast cancer	9.45e-05	0.000614	CcSEcCtD
Pethidine—Convulsion—Docetaxel—breast cancer	9.43e-05	0.000612	CcSEcCtD
Pethidine—Hypertension—Docetaxel—breast cancer	9.4e-05	0.00061	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—breast cancer	9.4e-05	0.00061	CcSEcCtD
Pethidine—Rash—Thiotepa—breast cancer	9.38e-05	0.000609	CcSEcCtD
Pethidine—Dermatitis—Thiotepa—breast cancer	9.38e-05	0.000609	CcSEcCtD
Pethidine—Headache—Thiotepa—breast cancer	9.32e-05	0.000605	CcSEcCtD
Pethidine—Somnolence—Paclitaxel—breast cancer	9.32e-05	0.000605	CcSEcCtD
Pethidine—Palpitations—Capecitabine—breast cancer	9.32e-05	0.000605	CcSEcCtD
Pethidine—Loss of consciousness—Capecitabine—breast cancer	9.26e-05	0.000602	CcSEcCtD
Pethidine—Nausea—Vinorelbine—breast cancer	9.26e-05	0.000601	CcSEcCtD
Pethidine—Asthenia—Mitoxantrone—breast cancer	9.22e-05	0.000599	CcSEcCtD
Pethidine—Asthenia—Irinotecan—breast cancer	9.22e-05	0.000599	CcSEcCtD
Pethidine—Decreased appetite—Paclitaxel—breast cancer	9.11e-05	0.000592	CcSEcCtD
Pethidine—Hypertension—Capecitabine—breast cancer	9.1e-05	0.000591	CcSEcCtD
Pethidine—Hypersensitivity—Fluorouracil—breast cancer	9.07e-05	0.000589	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—breast cancer	9.07e-05	0.000589	CcSEcCtD
Pethidine—Sweating—Epirubicin—breast cancer	9.01e-05	0.000585	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—breast cancer	8.98e-05	0.000583	CcSEcCtD
Pethidine—Constipation—Paclitaxel—breast cancer	8.96e-05	0.000582	CcSEcCtD
Pethidine—Confusional state—Docetaxel—breast cancer	8.96e-05	0.000582	CcSEcCtD
Pethidine—Anxiety—Capecitabine—breast cancer	8.94e-05	0.000581	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—breast cancer	8.89e-05	0.000577	CcSEcCtD
Pethidine—Oedema—Docetaxel—breast cancer	8.89e-05	0.000577	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—breast cancer	8.86e-05	0.000575	CcSEcCtD
Pethidine—Nausea—Thiotepa—breast cancer	8.84e-05	0.000574	CcSEcCtD
Pethidine—Dry mouth—Capecitabine—breast cancer	8.78e-05	0.00057	CcSEcCtD
Pethidine—Shock—Docetaxel—breast cancer	8.74e-05	0.000568	CcSEcCtD
Pethidine—Pruritus—Fluorouracil—breast cancer	8.71e-05	0.000566	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—breast cancer	8.69e-05	0.000565	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—breast cancer	8.69e-05	0.000564	CcSEcCtD
Pethidine—Confusional state—Capecitabine—breast cancer	8.67e-05	0.000563	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—breast cancer	8.67e-05	0.000563	CcSEcCtD
Pethidine—Feeling abnormal—Paclitaxel—breast cancer	8.64e-05	0.000561	CcSEcCtD
Pethidine—Oedema—Capecitabine—breast cancer	8.6e-05	0.000559	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—breast cancer	8.59e-05	0.000558	CcSEcCtD
Pethidine—Dizziness—Irinotecan—breast cancer	8.5e-05	0.000552	CcSEcCtD
Pethidine—Anorexia—Docetaxel—breast cancer	8.47e-05	0.00055	CcSEcCtD
Pethidine—Shock—Capecitabine—breast cancer	8.46e-05	0.00055	CcSEcCtD
Pethidine—Tachycardia—Capecitabine—breast cancer	8.4e-05	0.000545	CcSEcCtD
Pethidine—Sweating—Doxorubicin—breast cancer	8.34e-05	0.000541	CcSEcCtD
Pethidine—Urticaria—Paclitaxel—breast cancer	8.33e-05	0.000541	CcSEcCtD
Pethidine—Hyperhidrosis—Capecitabine—breast cancer	8.32e-05	0.00054	CcSEcCtD
Pethidine—Hypotension—Docetaxel—breast cancer	8.3e-05	0.000539	CcSEcCtD
Pethidine—Anorexia—Capecitabine—breast cancer	8.2e-05	0.000532	CcSEcCtD
Pethidine—Vomiting—Irinotecan—breast cancer	8.17e-05	0.000531	CcSEcCtD
Pethidine—Vomiting—Mitoxantrone—breast cancer	8.17e-05	0.000531	CcSEcCtD
Pethidine—Dizziness—Fluorouracil—breast cancer	8.14e-05	0.000529	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—breast cancer	8.13e-05	0.000528	CcSEcCtD
Pethidine—Rash—Mitoxantrone—breast cancer	8.1e-05	0.000526	CcSEcCtD
Pethidine—Rash—Irinotecan—breast cancer	8.1e-05	0.000526	CcSEcCtD
Pethidine—Dermatitis—Irinotecan—breast cancer	8.1e-05	0.000526	CcSEcCtD
Pethidine—Dermatitis—Mitoxantrone—breast cancer	8.1e-05	0.000526	CcSEcCtD
Pethidine—Headache—Mitoxantrone—breast cancer	8.05e-05	0.000523	CcSEcCtD
Pethidine—Headache—Irinotecan—breast cancer	8.05e-05	0.000523	CcSEcCtD
Pethidine—Hypotension—Capecitabine—breast cancer	8.04e-05	0.000522	CcSEcCtD
Pethidine—Insomnia—Docetaxel—breast cancer	8.04e-05	0.000522	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—breast cancer	7.96e-05	0.000517	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—breast cancer	7.95e-05	0.000516	CcSEcCtD
Pethidine—Somnolence—Docetaxel—breast cancer	7.9e-05	0.000513	CcSEcCtD
Pethidine—Rash—Gemcitabine—breast cancer	7.89e-05	0.000513	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—breast cancer	7.89e-05	0.000512	CcSEcCtD
Pethidine—Erythema—Methotrexate—breast cancer	7.85e-05	0.000509	CcSEcCtD
Pethidine—Headache—Gemcitabine—breast cancer	7.84e-05	0.000509	CcSEcCtD
Pethidine—Flushing—Epirubicin—breast cancer	7.83e-05	0.000508	CcSEcCtD
Pethidine—Vomiting—Fluorouracil—breast cancer	7.83e-05	0.000508	CcSEcCtD
Pethidine—Insomnia—Capecitabine—breast cancer	7.78e-05	0.000505	CcSEcCtD
Pethidine—Rash—Fluorouracil—breast cancer	7.76e-05	0.000504	CcSEcCtD
Pethidine—Dermatitis—Fluorouracil—breast cancer	7.76e-05	0.000504	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—breast cancer	7.72e-05	0.000502	CcSEcCtD
Pethidine—Hypersensitivity—Paclitaxel—breast cancer	7.72e-05	0.000501	CcSEcCtD
Pethidine—Headache—Fluorouracil—breast cancer	7.71e-05	0.000501	CcSEcCtD
Pethidine—Nausea—Irinotecan—breast cancer	7.64e-05	0.000496	CcSEcCtD
Pethidine—Nausea—Mitoxantrone—breast cancer	7.64e-05	0.000496	CcSEcCtD
Pethidine—Constipation—Docetaxel—breast cancer	7.6e-05	0.000493	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—breast cancer	7.52e-05	0.000488	CcSEcCtD
Pethidine—Asthenia—Paclitaxel—breast cancer	7.52e-05	0.000488	CcSEcCtD
Pethidine—Decreased appetite—Capecitabine—breast cancer	7.48e-05	0.000486	CcSEcCtD
Pethidine—Nausea—Gemcitabine—breast cancer	7.44e-05	0.000483	CcSEcCtD
Pethidine—Pruritus—Paclitaxel—breast cancer	7.42e-05	0.000482	CcSEcCtD
Pethidine—Constipation—Capecitabine—breast cancer	7.36e-05	0.000478	CcSEcCtD
Pethidine—Erythema—Epirubicin—breast cancer	7.34e-05	0.000477	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—breast cancer	7.32e-05	0.000475	CcSEcCtD
Pethidine—Nausea—Fluorouracil—breast cancer	7.31e-05	0.000475	CcSEcCtD
Pethidine—Flushing—Doxorubicin—breast cancer	7.24e-05	0.00047	CcSEcCtD
Pethidine—Feeling abnormal—Capecitabine—breast cancer	7.09e-05	0.00046	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—breast cancer	7.06e-05	0.000458	CcSEcCtD
Pethidine—Vertigo—Methotrexate—breast cancer	7.05e-05	0.000458	CcSEcCtD
Pethidine—Dizziness—Paclitaxel—breast cancer	6.93e-05	0.00045	CcSEcCtD
Pethidine—Urticaria—Capecitabine—breast cancer	6.83e-05	0.000444	CcSEcCtD
Pethidine—Convulsion—Methotrexate—breast cancer	6.8e-05	0.000441	CcSEcCtD
Pethidine—Erythema—Doxorubicin—breast cancer	6.79e-05	0.000441	CcSEcCtD
Pethidine—Agitation—Epirubicin—breast cancer	6.75e-05	0.000438	CcSEcCtD
Pethidine—Vomiting—Paclitaxel—breast cancer	6.67e-05	0.000433	CcSEcCtD
Pethidine—Rash—Paclitaxel—breast cancer	6.61e-05	0.000429	CcSEcCtD
Pethidine—Dermatitis—Paclitaxel—breast cancer	6.6e-05	0.000429	CcSEcCtD
Pethidine—Vertigo—Epirubicin—breast cancer	6.6e-05	0.000428	CcSEcCtD
Pethidine—Syncope—Epirubicin—breast cancer	6.59e-05	0.000428	CcSEcCtD
Pethidine—Headache—Paclitaxel—breast cancer	6.57e-05	0.000426	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—breast cancer	6.55e-05	0.000425	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—breast cancer	6.53e-05	0.000424	CcSEcCtD
Pethidine—Palpitations—Epirubicin—breast cancer	6.49e-05	0.000421	CcSEcCtD
Pethidine—Confusional state—Methotrexate—breast cancer	6.46e-05	0.000419	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—breast cancer	6.45e-05	0.000419	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—breast cancer	6.4e-05	0.000416	CcSEcCtD
Pethidine—Asthenia—Docetaxel—breast cancer	6.38e-05	0.000414	CcSEcCtD
Pethidine—Convulsion—Epirubicin—breast cancer	6.36e-05	0.000413	CcSEcCtD
Pethidine—Hypertension—Epirubicin—breast cancer	6.34e-05	0.000412	CcSEcCtD
Pethidine—Hypersensitivity—Capecitabine—breast cancer	6.34e-05	0.000412	CcSEcCtD
Pethidine—Pruritus—Docetaxel—breast cancer	6.29e-05	0.000408	CcSEcCtD
Pethidine—Agitation—Doxorubicin—breast cancer	6.24e-05	0.000405	CcSEcCtD
Pethidine—Anxiety—Epirubicin—breast cancer	6.23e-05	0.000405	CcSEcCtD
Pethidine—Nausea—Paclitaxel—breast cancer	6.23e-05	0.000404	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—breast cancer	6.19e-05	0.000402	CcSEcCtD
Pethidine—Asthenia—Capecitabine—breast cancer	6.17e-05	0.000401	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—breast cancer	6.11e-05	0.000397	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—breast cancer	6.1e-05	0.000396	CcSEcCtD
Pethidine—Anorexia—Methotrexate—breast cancer	6.1e-05	0.000396	CcSEcCtD
Pethidine—Syncope—Doxorubicin—breast cancer	6.09e-05	0.000396	CcSEcCtD
Pethidine—Pruritus—Capecitabine—breast cancer	6.09e-05	0.000395	CcSEcCtD
Pethidine—Confusional state—Epirubicin—breast cancer	6.04e-05	0.000392	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—breast cancer	6e-05	0.00039	CcSEcCtD
Pethidine—Oedema—Epirubicin—breast cancer	5.99e-05	0.000389	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—breast cancer	5.99e-05	0.000389	CcSEcCtD
Pethidine—Hypotension—Methotrexate—breast cancer	5.98e-05	0.000389	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—breast cancer	5.97e-05	0.000388	CcSEcCtD
Pethidine—Shock—Epirubicin—breast cancer	5.9e-05	0.000383	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—breast cancer	5.89e-05	0.000382	CcSEcCtD
Pethidine—Dizziness—Docetaxel—breast cancer	5.88e-05	0.000382	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—breast cancer	5.87e-05	0.000381	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—breast cancer	5.85e-05	0.00038	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—breast cancer	5.79e-05	0.000376	CcSEcCtD
Pethidine—Insomnia—Methotrexate—breast cancer	5.79e-05	0.000376	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—breast cancer	5.76e-05	0.000374	CcSEcCtD
Pethidine—Anorexia—Epirubicin—breast cancer	5.71e-05	0.000371	CcSEcCtD
Pethidine—Somnolence—Methotrexate—breast cancer	5.69e-05	0.00037	CcSEcCtD
Pethidine—Dizziness—Capecitabine—breast cancer	5.69e-05	0.000369	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—breast cancer	5.66e-05	0.000367	CcSEcCtD
Pethidine—Vomiting—Docetaxel—breast cancer	5.65e-05	0.000367	CcSEcCtD
Pethidine—Rash—Docetaxel—breast cancer	5.6e-05	0.000364	CcSEcCtD
Pethidine—Hypotension—Epirubicin—breast cancer	5.6e-05	0.000364	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—breast cancer	5.6e-05	0.000363	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—breast cancer	5.59e-05	0.000363	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—breast cancer	5.57e-05	0.000361	CcSEcCtD
Pethidine—Headache—Docetaxel—breast cancer	5.57e-05	0.000361	CcSEcCtD
Pethidine—Oedema—Doxorubicin—breast cancer	5.55e-05	0.00036	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—breast cancer	5.55e-05	0.00036	CcSEcCtD
Pethidine—Vomiting—Capecitabine—breast cancer	5.47e-05	0.000355	CcSEcCtD
Pethidine—Shock—Doxorubicin—breast cancer	5.46e-05	0.000354	CcSEcCtD
Pethidine—Rash—Capecitabine—breast cancer	5.42e-05	0.000352	CcSEcCtD
Pethidine—Insomnia—Epirubicin—breast cancer	5.42e-05	0.000352	CcSEcCtD
Pethidine—Dermatitis—Capecitabine—breast cancer	5.42e-05	0.000352	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—breast cancer	5.41e-05	0.000351	CcSEcCtD
Pethidine—Headache—Capecitabine—breast cancer	5.39e-05	0.00035	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—breast cancer	5.36e-05	0.000348	CcSEcCtD
Pethidine—Somnolence—Epirubicin—breast cancer	5.33e-05	0.000346	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—breast cancer	5.29e-05	0.000343	CcSEcCtD
Pethidine—Nausea—Docetaxel—breast cancer	5.28e-05	0.000343	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—breast cancer	5.28e-05	0.000343	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—breast cancer	5.21e-05	0.000338	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—breast cancer	5.18e-05	0.000336	CcSEcCtD
Pethidine—Constipation—Epirubicin—breast cancer	5.13e-05	0.000333	CcSEcCtD
Pethidine—Nausea—Capecitabine—breast cancer	5.11e-05	0.000332	CcSEcCtD
Pethidine—Urticaria—Methotrexate—breast cancer	5.09e-05	0.00033	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—breast cancer	5.02e-05	0.000326	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—breast cancer	4.94e-05	0.000321	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—breast cancer	4.93e-05	0.00032	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—breast cancer	4.82e-05	0.000313	CcSEcCtD
Pethidine—Urticaria—Epirubicin—breast cancer	4.76e-05	0.000309	CcSEcCtD
Pethidine—Constipation—Doxorubicin—breast cancer	4.74e-05	0.000308	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—breast cancer	4.72e-05	0.000306	CcSEcCtD
Pethidine—Asthenia—Methotrexate—breast cancer	4.59e-05	0.000298	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—breast cancer	4.57e-05	0.000297	CcSEcCtD
Pethidine—Pruritus—Methotrexate—breast cancer	4.53e-05	0.000294	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—breast cancer	4.42e-05	0.000287	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—breast cancer	4.41e-05	0.000286	CcSEcCtD
Pethidine—Asthenia—Epirubicin—breast cancer	4.3e-05	0.000279	CcSEcCtD
Pethidine—Pruritus—Epirubicin—breast cancer	4.24e-05	0.000275	CcSEcCtD
Pethidine—Dizziness—Methotrexate—breast cancer	4.23e-05	0.000275	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—breast cancer	4.09e-05	0.000265	CcSEcCtD
Pethidine—Vomiting—Methotrexate—breast cancer	4.07e-05	0.000264	CcSEcCtD
Pethidine—Rash—Methotrexate—breast cancer	4.04e-05	0.000262	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—breast cancer	4.03e-05	0.000262	CcSEcCtD
Pethidine—Headache—Methotrexate—breast cancer	4.01e-05	0.00026	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—breast cancer	3.98e-05	0.000258	CcSEcCtD
Pethidine—Dizziness—Epirubicin—breast cancer	3.96e-05	0.000257	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—breast cancer	3.92e-05	0.000255	CcSEcCtD
Pethidine—Vomiting—Epirubicin—breast cancer	3.81e-05	0.000247	CcSEcCtD
Pethidine—Nausea—Methotrexate—breast cancer	3.8e-05	0.000247	CcSEcCtD
Pethidine—Rash—Epirubicin—breast cancer	3.78e-05	0.000245	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—breast cancer	3.78e-05	0.000245	CcSEcCtD
Pethidine—Headache—Epirubicin—breast cancer	3.75e-05	0.000244	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—breast cancer	3.67e-05	0.000238	CcSEcCtD
Pethidine—Nausea—Epirubicin—breast cancer	3.56e-05	0.000231	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—breast cancer	3.53e-05	0.000229	CcSEcCtD
Pethidine—Rash—Doxorubicin—breast cancer	3.5e-05	0.000227	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—breast cancer	3.49e-05	0.000227	CcSEcCtD
Pethidine—Headache—Doxorubicin—breast cancer	3.47e-05	0.000226	CcSEcCtD
Pethidine—Nausea—Doxorubicin—breast cancer	3.29e-05	0.000214	CcSEcCtD
Pethidine—CYP3A4—Metabolism—GPX2—breast cancer	3.79e-06	3.23e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP3A4—breast cancer	3.77e-06	3.22e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOS3—breast cancer	3.76e-06	3.21e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GPX1—breast cancer	3.76e-06	3.21e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.76e-06	3.2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FASN—breast cancer	3.75e-06	3.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX4—breast cancer	3.74e-06	3.19e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SULT1A1—breast cancer	3.74e-06	3.19e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BCHE—breast cancer	3.73e-06	3.18e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—breast cancer	3.72e-06	3.17e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—breast cancer	3.72e-06	3.17e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1B1—breast cancer	3.71e-06	3.17e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ERCC2—breast cancer	3.69e-06	3.15e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—breast cancer	3.69e-06	3.14e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—breast cancer	3.67e-06	3.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IDH1—breast cancer	3.65e-06	3.12e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA1—breast cancer	3.65e-06	3.12e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.65e-06	3.11e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.64e-06	3.1e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—breast cancer	3.62e-06	3.09e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—COMT—breast cancer	3.61e-06	3.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAT2—breast cancer	3.61e-06	3.08e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—breast cancer	3.6e-06	3.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—breast cancer	3.6e-06	3.07e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	3.59e-06	3.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—breast cancer	3.57e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.56e-06	3.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—breast cancer	3.56e-06	3.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAF1—breast cancer	3.56e-06	3.04e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—breast cancer	3.55e-06	3.03e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RELA—breast cancer	3.54e-06	3.02e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOA1—breast cancer	3.54e-06	3.02e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ITPR1—breast cancer	3.54e-06	3.02e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—breast cancer	3.52e-06	3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—breast cancer	3.51e-06	2.99e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT2—breast cancer	3.51e-06	2.99e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—breast cancer	3.49e-06	2.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—STK11—breast cancer	3.49e-06	2.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP19A1—breast cancer	3.49e-06	2.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—breast cancer	3.47e-06	2.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—breast cancer	3.47e-06	2.96e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.47e-06	2.96e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—breast cancer	3.47e-06	2.96e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—breast cancer	3.42e-06	2.92e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1B1—breast cancer	3.41e-06	2.91e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—breast cancer	3.4e-06	2.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—breast cancer	3.37e-06	2.87e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.35e-06	2.86e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—breast cancer	3.34e-06	2.85e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—breast cancer	3.34e-06	2.85e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.34e-06	2.85e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—breast cancer	3.33e-06	2.84e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—breast cancer	3.32e-06	2.83e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—breast cancer	3.32e-06	2.83e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—breast cancer	3.3e-06	2.82e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NCOR1—breast cancer	3.3e-06	2.82e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PLA2G4A—breast cancer	3.3e-06	2.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—breast cancer	3.3e-06	2.81e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.27e-06	2.79e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—breast cancer	3.26e-06	2.78e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOA1—breast cancer	3.26e-06	2.78e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—COMT—breast cancer	3.24e-06	2.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—breast cancer	3.23e-06	2.75e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—breast cancer	3.23e-06	2.75e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.21e-06	2.74e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—STK11—breast cancer	3.21e-06	2.74e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAV1—breast cancer	3.2e-06	2.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—breast cancer	3.2e-06	2.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—breast cancer	3.19e-06	2.72e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—breast cancer	3.18e-06	2.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOS3—breast cancer	3.18e-06	2.71e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ITPR1—breast cancer	3.18e-06	2.71e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—breast cancer	3.17e-06	2.71e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MED12—breast cancer	3.17e-06	2.7e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DPYD—breast cancer	3.17e-06	2.7e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GPX1—breast cancer	3.16e-06	2.7e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—breast cancer	3.13e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDOA—breast cancer	3.12e-06	2.66e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—breast cancer	3.11e-06	2.65e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ERCC2—breast cancer	3.11e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—breast cancer	3.1e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—breast cancer	3.08e-06	2.63e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—breast cancer	3.08e-06	2.62e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—breast cancer	3.06e-06	2.61e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	3.03e-06	2.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA3—breast cancer	3.03e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—breast cancer	3.02e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—breast cancer	3.02e-06	2.57e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—breast cancer	3.01e-06	2.57e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAF1—breast cancer	3.01e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A2—breast cancer	3.01e-06	2.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—breast cancer	3e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—breast cancer	3e-06	2.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RELA—breast cancer	2.99e-06	2.55e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—COMT—breast cancer	2.98e-06	2.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.98e-06	2.54e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—breast cancer	2.97e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—breast cancer	2.97e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.97e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOR1—breast cancer	2.97e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CPT1A—breast cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG2—breast cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTR—breast cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—breast cancer	2.94e-06	2.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.94e-06	2.5e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.93e-06	2.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—breast cancer	2.93e-06	2.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ITPR1—breast cancer	2.92e-06	2.49e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—breast cancer	2.92e-06	2.49e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.91e-06	2.49e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGDS—breast cancer	2.89e-06	2.46e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HBA1—breast cancer	2.87e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPX1—breast cancer	2.84e-06	2.42e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—breast cancer	2.83e-06	2.41e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.82e-06	2.41e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—breast cancer	2.81e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—breast cancer	2.81e-06	2.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.8e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—breast cancer	2.8e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ACHE—breast cancer	2.8e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ERCC2—breast cancer	2.79e-06	2.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—breast cancer	2.78e-06	2.37e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—breast cancer	2.76e-06	2.35e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.76e-06	2.35e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—breast cancer	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOR1—breast cancer	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—breast cancer	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—breast cancer	2.71e-06	2.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—breast cancer	2.7e-06	2.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—breast cancer	2.7e-06	2.3e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAV1—breast cancer	2.69e-06	2.3e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—breast cancer	2.69e-06	2.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—breast cancer	2.68e-06	2.29e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.65e-06	2.26e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—breast cancer	2.63e-06	2.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS1—breast cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO1—breast cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—breast cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—breast cancer	2.62e-06	2.24e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—breast cancer	2.62e-06	2.23e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPX1—breast cancer	2.61e-06	2.23e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.6e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.59e-06	2.21e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ERCC2—breast cancer	2.57e-06	2.19e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.57e-06	2.19e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—breast cancer	2.56e-06	2.19e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—breast cancer	2.55e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.54e-06	2.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—breast cancer	2.54e-06	2.16e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—breast cancer	2.53e-06	2.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA2—breast cancer	2.53e-06	2.15e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—breast cancer	2.49e-06	2.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.49e-06	2.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.48e-06	2.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.48e-06	2.11e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—breast cancer	2.45e-06	2.09e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FASN—breast cancer	2.45e-06	2.09e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—breast cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BCHE—breast cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NOS3—breast cancer	2.42e-06	2.06e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAV1—breast cancer	2.42e-06	2.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—breast cancer	2.41e-06	2.06e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.41e-06	2.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—breast cancer	2.35e-06	2.01e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—breast cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—breast cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—breast cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—breast cancer	2.29e-06	1.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—breast cancer	2.27e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—breast cancer	2.23e-06	1.91e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.23e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAV1—breast cancer	2.22e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—breast cancer	2.21e-06	1.89e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—breast cancer	2.2e-06	1.88e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—breast cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—breast cancer	2.16e-06	1.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA1—breast cancer	2.13e-06	1.82e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—breast cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—breast cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—breast cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—STK11—breast cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—breast cancer	2.06e-06	1.76e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—breast cancer	2.05e-06	1.75e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NOS3—breast cancer	2.04e-06	1.74e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.03e-06	1.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—breast cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COMT—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—breast cancer	1.94e-06	1.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—breast cancer	1.93e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ITPR1—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—breast cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—breast cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—breast cancer	1.86e-06	1.59e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—breast cancer	1.84e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NOS3—breast cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—breast cancer	1.8e-06	1.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.79e-06	1.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOR1—breast cancer	1.78e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—breast cancer	1.78e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.78e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.78e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—breast cancer	1.76e-06	1.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—breast cancer	1.73e-06	1.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—breast cancer	1.73e-06	1.48e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX1—breast cancer	1.71e-06	1.46e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NOS3—breast cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ERCC2—breast cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—breast cancer	1.67e-06	1.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—breast cancer	1.62e-06	1.39e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—breast cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—breast cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.55e-06	1.32e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—breast cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—breast cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAV1—breast cancer	1.45e-06	1.24e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—breast cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.16e-06	9.93e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—breast cancer	1.15e-06	9.81e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—breast cancer	1.15e-06	9.78e-06	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—breast cancer	1.11e-06	9.49e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NOS3—breast cancer	1.1e-06	9.38e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.03e-06	8.78e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.01e-06	8.66e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—breast cancer	1.01e-06	8.58e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—breast cancer	9.46e-07	8.07e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—breast cancer	9.36e-07	7.99e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—breast cancer	8.77e-07	7.48e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—breast cancer	8.41e-07	7.17e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—breast cancer	7.73e-07	6.59e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—breast cancer	6.19e-07	5.28e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—breast cancer	5.05e-07	4.31e-06	CbGpPWpGaD
